Surgical treatment of a foscavir-resistant atypical Cytomegalovirus pneumonia in an allogeneic stem cell transplant recipient.
Bressollette-Bodin
C
C
Virology laboratory, University Hospital Hotel Dieu and JE2437 Génétique des interactions hôte-microorganismes, IFR26, Nantes, France. celine.bressollette@chu-nantes.fr
Claver
A
A
Boutolleau
D
D
Chevallier
P
P
Guillaume
T
T
Gastinne
T
T
Moreau
P
P
Harousseau
J-L
JL
Imbert-Marcille
B M
BM
Le Gouill
S
S
D000998:Antiviral Agents / Q000494:pharmacology*; D003586:Cytomegalovirus Infections / Q000601:surgery* / Q000628:therapy; D004259:DNA-Directed DNA Polymerase / Q000235:genetics; D024882:Drug Resistance, Viral; D005260:Female; D017245:Foscarnet / Q000494:pharmacology*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000628:therapy; D008875:Middle Aged; D011024:Pneumonia, Viral / Q000601:surgery* / Q000628:therapy / Q000821:virology; D011110:Polymorphism, Genetic; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D014184:Transplantation, Homologous / Q000379:methods; D016896:Treatment Outcome; D019562:Viral Load; D014764:Viral Proteins / Q000235:genetics
D000998:Antiviral Agents; C109367:UL54 protein, Human herpesvirus 5; D014764:Viral Proteins; D017245:Foscarnet; D004259:DNA-Directed DNA Polymerase